Percutaneous Transseptal Myocardial Ablation with Wire (PTSAW): A New Technique

Journal of Invasive Cardiology

Volumn 16, Issue 4, 2004, Pages 204-206

  Trehan, Vijay ^a   Mukhopadhyay, Saibal ^a,b   Rangasetty, Umamahesh C ^a  

^a G B PANT HOSPITAL   (India)

^b Department of Cardiology ^*  (India)

Author keywords

Floppy tips of percutaneous transluminal coronary angioplasty guidewire; Hypertrophic obstructive cardiomyopathy; Left ventricular outflow tract obstruction

Indexed keywords

ALCOHOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DYSPNEA; ELECTROCARDIOGRAPHY; FOLLOW UP; GUIDE WIRE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART SURGERY; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMAGE ANALYSIS; MALE; MYOMECTOMY; PERCUTANEOUS TRANSSEPTAL MYOCARDIAL ABLATION; SHORT SURVEY; SYMPTOM; SYNCOPE; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ELECTROCARDIOGRAPHY; ETHANOL; HEART SEPTUM; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCARDIAL INFARCTION;

EID: 1842423689     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. Trehan VK, Arora R, Mukhopadhyay S, et al. Percutaneous closure of coronary pulmonary arterial fistula using catheterization laboratory trash. Cathet Cardiovasc Interven 2003;59:49-51.
2. Spirito P, Seidman CE, McKenna WJ, et al. The management of hypertrophic cardiomyopathy. N Eng J Med 1997;336:775-785.
3. Nagueh SF, Omnen SR, Lakkis NM, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;38:1701-1706.
4. Xin J, Shiota T, Lever HM, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 2001;38:1994-2000.
5. Sigwart U. Non surgical myocardial reduction of hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-214.
6. Knight C, Kurbaan AS, Seggewiss H, et al. Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in first series of patients. Circulation 1997;95:2075-2081.
7. Seggewiss H, Gleichmann U, Faber L, et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3 months follow up in 25 patients. J Am Coll Cardiol 1998;31:252-258.
8. Spencer WH and Roberts R. Alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 2000;102:600-601.
9. Geitzen FH, Leiuer CJ, Raute Kriensen U, et al. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic cardiomyopathy. Eur Heart J 1999;20:1342-1354.
10. Faber L, Meissner A, Ziemssen P, Seggeweiss H. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Long-term follow-up of the first series of 25 patients. Heart 2000;84:326-331.
11. Oomman A, Ramachandran P, Subramanian K, et al. Percutaneous transluminal septal myocardial ablation in drug-resistant hypertrophic obstructive cardiomyopathy, 18-month follow up results. J Invas Cardiol 2001;13:326-330.
12. Boekstegers P, Steinbigler P, Molnar A, et al. Pressure-guided non surgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;38:846-853.
13. Vanderheyden M, Willaert W, Claessens P. Non-alcoholic percutaneous transluminal septal ablation for hypertrophic cardiomyopathy with obstruction. Am J Cardiol 2002;89:361-362.